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Aim: To investigate the presence of Helicobacter pylori (H. pylori) in bronchial biopsies
of patients with bronchiectasis, by histochemical and immunochemical staining.
Setting: 800-bed tertiary university hospital.
Methods: Observational study. Patients: forty-six patients with bronchiectasis in a
stable clinical condition and 8 control patients. Interventions: Serum samples
determination of IgG levels for H. pylori by ELISA. Inmunostaining with an anti-H.
pylori antibody (NCL-HPp, Novocastra) of bronchial mucosa obtained by fiberoptic
bronchoscopy from both patients with bronchiectasis and controls.
Results: Twenty-one out of 46 patients with bronchiectasis (46%) had positive
serologies for H. pylori. We obtained 40 bronchial biopsies in patients with
bronchiectasis and 8 bronchial biopsies in control patients. No evidence of H. pylori
was obtained in the bronchial samples of both patients and controls.
Conclusions: The results of our study could not demonstrate the presence of H.
pylori in bronchial specimens from patients with bronchiectasis.
& 2005 Elsevier Ltd. All rights reserved.Elsevier Ltd. All rights reserved.
2275400; fax: +34 93 227 54 54.
s (J. Angrill).
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Bronchiectasis is a chronic pulmonary disease
characterized by an irreversible dilatation of the
bronchi. The current view of the pathogenesis of
bronchiectasis considers initial aggression to the
lower respiratory tract by different microorganisms
as the first step leading to an inflammatory
destruction of the bronchial wall.1 Pertussis,
measles and Mycobacterium tuberculosis are con-
sidered the most common etiologic agents causing
bronchiectasis, particularly in non-developed coun-
tries.2
Helicobacter pylori has been recently identified
as a potential pathogenic microorganisms causing
gastric (gastritis, peptic ulcer and gastric lympho-
ma) and non-gastric associated disorders (isquemic
heart and cerebrovascular diseases and rosacea).3,4
In this way previous reports identified H. pylori in
non-gastric reservoirs such as tracheobronchial
aspirates in mechanically ventilated patients and
nasal or maxillary sinus specimens from patients
with chronic sinusitis.5 Recently, Tsang et al.
evaluated serum IgG levels against H. pylori in
patients with idiopathic bronchiectasis and found a
significant positivity of H. pylori in patients with
bronchiectasis compared with patients with tuber-
culosis and healthy volunteers suggesting a patho-
genic role of H. pylori in the pathogenic of this
disorder.6
There are interesting similarities between the
pathogenesis of bronchiectasis and ulcerogenesis.
In both conditions, there is extensive recruitment
of neutrophils and T lymphocytes into the sub-
mucosa and cytokine release of interleukin-8, TNF-
alpha and IL-1.7,8
Despite the similarities in the pathogenesis of
bronchiectasis and peptic ulcer disease, and the
high seroprevalence of H. pylori in bronchiectasis,
the possible pathogenic role of H. pylori in
bronchiectasis remains unexplored. We carried
out this prospective study to evaluate the pre-
valence of H. pylori in patients with bronchiectasis
using serologies and the possible role of this
microorganism in the pathogenesis of bronchiecta-
sis by identification of this microorganism in
bronchial biopsies.Methods
Patients
We studied 46 patients with bronchiectasis, diag-
nosed by clinical and high-resolution chest CT
(HRCT) scan criteria, in a stable clinical situation.infectious bronchiectasis, 13 idiopathic bronchiec-
tasis, 1 reumatoid arthritis, 1 primary ciliar
diskynesia, and 1 Young syndrome. Patients with
an increase in the volume or a change in the
macroscopic characteristics of the sputum as well
as an increase in the degree of dyspnea or presence
of fever were considered to have an exacerbation.
They were excluded from the study if the episode
of exacerbation occurred within the last 2 months
or if they had received antibiotics or corticoster-
oids within the last month before the initiation of
the study. Risk factors for H. pylori infection as age,
sex and socio-economic status were evaluated in
each patient.
Eight non-smoker subjects without respiratory
disease were included in the study as controls.
Clinical reasons to perform a bronchoscopy in
control patients were search for primary malig-
nancy in patients with a solitary metastasis of the
brain and suspicion of upper airway disease. In each
instance, the bronchoscopic exploration was nor-
mal and microbiologic cultures negative.Study protocol
The Ethical Committee of the Hospital Clinic
approved the study protocol. Informed consent
was obtained from all the patients.
The day of the study, a complete clinical
evaluation and a forced spirometry (Collins Survey
III, plus, USA) were performed before the broncho-
scopic examination.
An HRCT scan of the thorax was performed in all
the patients with bronchiectasis within the 3
months previous to the bronchoscopic examination.
Upper airway anesthesia for bronchoscopic ex-
amination was achieved by nebulization of 8ml
lidocaine 5% through a buccal clip for 15min. The
bronchoscope (Olympus BF 30; New Hyde Park, NY,
USA) was passed transnasally or transorally into the
trachea, avoiding any suction through the inner
channel, and bronchial biopsies were performed in
the lobe with more involvement by bronchiectasis
according to the chest CT scan.Serologic examination
The serum of all subjects with bronchiectasis
enrolled in the study were evaluated by an
enzyme-linked immunosorbent assay (ELISA) IgG
test for H. pylori identification (H. pylori IgG ELISA,
Wampole Laboratories, Dist., Cranbury, NJ) in
accordance with the manufacturer’s guidelines.
Positive, borderline, and negative results were
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against H. pylori was greater than 1.10, between
0.91–1.09 and less than 0.90 U/ml, respectively.
Bronchial biopsy analysis
One bronchial biopsy was obtained from the carina
of subsegmental bronchi in the most affected areas
by bronchiectasis suggested by chest CT scan in
patients with bronchiectasis and in non-selected
areas in control patients.
Bronchial biopsy specimens were fixed in 10%
formaldehyde and paraffin-embedded. Conven-
tional 4-mm histological sections were cut and
stained with hematoxylin-eosin (HE) and Giemsa.
The histological sections were evaluated for the
presence or absence of columnar epithelium,
presence or absence of epithelial lesions, presence
of inflammatory infiltrate in the lamina propia and
presence of microorganisms. Immunostaining was
performed with an anti-H. pylori antibody (NCL-
HPp, Novocastra), at 1:10 dilution, after tissue
treatment with pepsin, using the EnVision (Dako)
amplification system. Only samples with preserved
epithelium were considered acceptable for histo-
logical evaluation. This is in accordance with the
hypothesis that H. pylori is attached to the super-
ficial cells of the mucosa as occurs in gastric
samples where the organisms are present at the
luminal surface of the epithelium.
Two endoscopic biopsies with active chronic
gastritis secondary to H. pylori and associated with
moderate/marked amount of microorganisms pre-
sent at the surface of the epithelium were used as
positive controls. Replacement of the primary
antibody by PBS was used as negative control.
Statistical analysis
Data are presented as frequencies and percentages
for qualitative variables and as mean and standardTable 1 Clinical characteristics and spirometric values o
Bronchiectasis
Sex M/F 16/30
Age yr. 57(14)
Smoking habit (Y/N) 3/43
FEV1 (%) 79(21)
FVC (%) 84(17)
FEV1/FVC (%) 70(10)
Values are expressed as a mean (SD).
Definition of abbreviations: Y: yes, N: no, M: male; F: female; FEV
NS: not significant.
FEV1 and FVC are expressed as percentages of predicted values.deviation for quantitative variables. Chi-square
test or the Fisher’s exact test for comparison of
categorical variables when appropriate and t-
student test for comparison of quantitative vari-
ables were performed. All reported p values are
two-tailed. The level of significance was estab-
lished as 5% for all analyses.Results
Patients
The main clinical characteristics and spirometric
values of the patients enrolled in the study are
summarized in Table 1. Women constituted 65% of
the patients evaluated. Only three (6%) patients
were current smokers and eight (17%) were ex-
smokers. Twenty-nine patients (63%) had chronic
expectoration. The potential pulmonary insult
causing bronchiectasis occurred before the age of
14 years in 28 (60%) subjects. Although, the mean
spirometric values were almost within the range of
normality, the values of both FVC and FEV1 were
significantly lower than those observed in control
subjects. Twenty-four (52%) patients showed air-
flow obstruction with a FEV1/FVCo70% and
FEV1o80% predicted. Thirty-four (74%) patients
had cylindrical bronchiectasis according to the
HRCT scan, eight (16%) cystic bronchiectasis and
four (8%) varicose bronchiectasis. Twenty patients
(43%) had inflammatory infiltrates associated with
bronchiectasis.Helicobacter pylori seroprevalence
Forty-six patients with bronchiectasis were evalu-
ated with determination of IgG anti-H. pylori.
Twenty-one (46%) patients were positive for
H. pylori.f patients with bronchiectasis and controls.
Controls P
4/4 NS
58(13) NS
0/8 NS
103(10) 0.003
98(9) 0.02
79(7) 0.025
1: forced expiratory volume in 1 s; FVC: forced vital capacity;
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We obtained a total of 48 bronchial samples, 40 in
patients with bronchiectasis and 8 control patients.
Of these 48 biopsies, only 38 were further
processed for analysis (21 samples from 21 patients
with bronchiectasis and positive serology, 10 from
25 patients with bronchiectasis and negative
serology and 7 samples from 8 control patients).
The remaining samples were excluded since they
showed slaughtering/detachment of the surface
epithelium.
There were no differences in clinical, spirometric
parameters and seroprevalence of H. pylori in
patients with non-acceptable bronchial biopsies,
compared to patients with good quality samples.
Mild inflammatory infiltrate of the lamina propia,
composed by mature lymphocytes, was observed in
14 patients with bronchiectasis. In only one case a
mixed acute and chronic inflammatory infiltrate
was observed. No inflammatory changes were found
in control cases. No significative differences be-
tween HE and Giemsa stains were observed, and no
infectious structures could be identified. Immuno-
histochemical staining was performed in all of the
cases considered acceptable ðn ¼ 31Þ and seven
control cases. None of them showed presence of H.
pylori.Discussion
The results of the present study do not support a
pathogenic role of H. pylori in patients with
bronchiectasis in a clinical stable condition.
The capacity of H. pylori to reach the lower
airways coupled with the histopathological simila-
rities between bronchiectasis and gastric peptic
ulcer has prompt some investigators to raise the
hypothesis that H. pylori might be implicated in the
pathogenesis of some cases of bronchiectasis.
Supporting this, different authors9–11 have shown
an increased prevalence of serum antibodies
against H. pylori in patients with both chronic
bronchitis and bronchiectasis. The presence of H.
pylori in dental plaques, tonsils and adenoids
suggest that the oral cavity is a reservoir of this
microorganism. Another possible origin for H. pylori
bronchial colonization is the gastric reservoir, in
that gastro esophageal reflux could be a predispos-
ing factor for H. pylori transport to the oropharinx
and bronchial lumen. A direct transmission or
inhalation of H. pylori from these structures is thus
possible and seems to be confirmed in previous
reports that isolate this micro organism in the
tracheobronchial aspirates of mechanically venti-lated patients. To try to confirm this hypothesis,
llvan et al. in a recently published work evaluated
the presence of H. pylori by means of rapid urease
tests, cultures and histopathological examination
of bronchial samples with negative results.23 A
potential criticism of the manuscript by llvan et al.
is that the population evaluated was very selected
since it was constituted by young male soldiers
without gastrointestinal pathology and it is known
that aging and gastrointestinal pathology are both
risk factors for H. pylori infection. To try to
circumvent this limitation, the present study
evaluated a more heterogeneous population that
included patients of both sexes, with a mean age of
56 years and in whom the presence of gastrointest-
inal disorders was not accounted for. Despite this,
our results confirm those obtained by llvan et al. in
that the presence of H. pylori was not demon-
strated in the bronchial biopsies of patients with
bronchiectasis.
Our results confirm and expand those obtained by
llvan et al., in a more heterogeneous population of
patients with bronchiectasis in stable clinical
condition. Furthermore, and contrary to llvan
et al., we did not exclude patients with gastro-
intestinal pathology, since one possible way to H.
pylori colonization and infection of the respiratory
tract may be inhalation of the microorganism from
the gastrointestinal tract.
Caselli et al.,9 Rosenstock et al.,10 Roussos
et al.,11 in patients with chronic bronchitis and
Tsang et al. in patients with bronchiectasis6
previously evidenced increased seroprevalence of
H. pylori, suggesting a pathogenic role of H. pylori.
This association might reflect either susceptibility
induced by common factors or a kind of causal
relationship between these two conditions. It is
well known that age, sex and socio-economic status
are related with both H. pylori infection and risk of
developing chronic bronchitis.
We determined Hp-specific IgG in our patients,
and we did not find differences of H. pylori
seropositivity between bronchiectasis patients and
our general population seropositivity expressed in
previous Spanish epidemiological studies.12–14
As far as we know, there are not a gold standard
method to evaluate the presence of H. pylori into
the respiratory tract, neither the identification of
H. pylori species in human bronchial tissue, nor the
isolation of H. pylori from respiratory specimens as
bronchoalveolar lavage (BAL) fluid has been
achieved to date in patients with bronchiectasis.
Taken into account the potential limitations of
respiratory specimens and based of the extense
previous experience to study H. pylori in gastric
biopsies we decided to choose bronchial biopsy
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into the lower respiratory tract.
Bacterial culture is a specific method and has an
advantage that inform about organism’s suscept-
ibility. However, it is less sensitive than histologic
examination currently, due to running time, lack of
sensitivity, the fastidious growth requirements of
H. pylori, irreproducibility, and no single method
was approved as an ideal. Although respiratory
specimens could be contaminated because H.
pylori is found in the dental plaques and saliva,
this could be enhanced by non-contaminated
respiratory specimens as bronchoalveolar lavage
(BAL). Recently, Lehours et al. compared the
accuracy and precision of different techniques for
the diagnosis of H. pylori infection as culture,
histology, PCR and serology and found that histol-
ogy and serology were the test methods with the
highest sensitivity, while PCR and culture only
provided for 50% sensitivity.15
To achieve the histological identification of H.
pylori infection in gastric biopsies several staining
methods are in use. These include modified
Giemsa, Warthin-Starry, Genta, Gimenez and im-
munohistochemical H. pylori antibody stains. Re-
cently Rotimi and colleagues showed that when H.
pylori are present, careful examination with
modified Giemsa stain is the method of choice
because it is sensitive, cheap, easy to perform, and
reproducible16 while immunohistochemistry is the
agreed ‘‘gold standard’’ for histology, being a highly
sensitive and specific and staining method.17 As
previously reported studies, immunostain is offset
by the increased expense of reagents and the time
taken for each slide and we decided to reserve this
procedure in selected and doubtful specimens.
Additionally to potential limitations associated to
staining method, another possible limitation were
the kind of tissue. We obtain bronchial biopsy
specimens from proximal bronchi in the most
affected area as chest CT scan showed but not
directly in the area of bronchiectasis. Furthermore,
sampling error, presumably caused by a supposedly
patchy distribution of H. pylori as occur on the
gastric mucosa and low numbers of H. pylori below
the limit of histologic detection, could be respon-
sible on false negative results. The negative results
do not permit to assume a possible role suggested by
previous serological studies of H. pylori in bronch-
iectasis as a colonizing or causative pathogen.
As far as we know, there are no common factors
implicated in the susceptibility to both bronchiec-
tasis and H. pylori infection, but we could
hypothesize an origin from the spilling or inhalation
of H. pylori or its exotoxins into the respiratory
tract from upper respiratory territories or gastricreservoir. Recently, attention has been directed
toward the presence of H. pylori in other anatomic
reservoirs as dental plaque, tonsils, adenoids
suggesting the oral cavity as a reservoir for
systemic infections.18,19 Minocha et al. on patients
who had undergone tonsillectomy found fewer
gastric H. pylori colonizations in the following
months,20 because the oral or sinus cavities are
located near the respiratory tract a direct trans-
mission or inhalation of H. pylori infection from
these structures may be considered in patients with
bronchiectasis. In this way another possible origin
for H. pylori bronchial colonization is the gastric
reservoir, so gastroesophageal reflux (GER) could be
a predisposing factor to H. pylori transport to the
oropharinx or bronchial lumen. It has been sug-
gested that direct reflux of gastric juice into the
oropharinx and nasal mucosa may cause mucosal
edema and inflammation, leading to secondary
obstruction of sinus ostium, and secondary chronic
sinus inflammation, but the exact mechanism
remains unclear. Morinaka et al. found H. pylori
positive biopsy specimens of the sinus and nasal
mucosa from patients with chronic sinusitis, sug-
gesting a pathogenic role of H. pylori in the
respiratory mucosa.5 How H. pylori is transmitted
remains unclear and little is known about its role in
extragastric disease. Previous reports identified H.
pylori in the tracheobronchial aspirates in me-
chanically ventilated patients and the possibility
that it might cause ventilator associated pneumo-
nia has increased.21 In addition, other bacteria
found in the gastric juice have been isolated from
the respiratory tract in situations that favored
bacterial colonization of the stomach and where
regurgitation of gastric contents into the respira-
tory tract can occur.22
The results of our study could not demonstrate H.
pylori itself in bronchial specimens from patients
with bronchiectasis. In order to be more certain
about the role of H. pylori in bronchiectasis,
further studies should be undertaken to clarify
the pathogenetic mechanisms underlying the pos-
sible association between these diseases.References
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